Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
08/2005
08/31/2005EP1567494A1 Methods for preparing phenylalkyne derivatives
08/31/2005EP1567477A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
08/31/2005EP1567010A1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
08/31/2005EP1011676B1 Quinoline-urea derivatives for the treatment of withdrawal syndrome and withdrawal-induced brain damage
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1660818A Process for the manufacture of organic compounds
08/31/2005CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/30/2005US6936615 Heteroaryl derivatives and their use as medicaments
08/30/2005CA2336968C Quinoline derivatives
08/25/2005WO2005077947A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
08/25/2005WO2005077904A1 Process for preparing aripiprazole
08/25/2005WO2005077903A2 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077884A2 Hydroaminomethylation of olefins
08/25/2005WO2005076861A2 Compounds that inhibit hiv particle formation
08/25/2005WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
08/25/2005US20050187375 Polymers and oligomers, their synthesis, and electronic devices incorporating same
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050187245 Stable amorphous forms of montelukast sodium
08/25/2005US20050187244 Montelukast sodium polymorphs
08/25/2005US20050187243 Montelukast free acid polymorphs
08/25/2005US20050187230 Compounds and compositions as protein kinase inhibitors
08/25/2005CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
08/25/2005CA2555289A1 Process for preparing aripiprazole
08/25/2005CA2555132A1 Compounds that inhibit hiv particle formation
08/25/2005CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/24/2005EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
08/24/2005EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659146A Process for the manufacture of quinoline derivatives
08/24/2005CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/23/2005US6933388 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolones
08/18/2005WO2005075430A1 Process for preparing purified ciprofloxacin
08/18/2005WO2005075429A1 Novel quinoline-carbaxamides as jack3 kinase modulators
08/18/2005WO2005075428A1 Quinoline derivatives for use as mycobacterial inhibitors
08/18/2005WO2005075427A2 Montelukast sodium polymorphs
08/18/2005WO2005074935A1 Montelukast free acid polymorphs
08/18/2005WO2005074919A1 Diurea derivatives
08/18/2005WO2005074893A1 Stable amorphous forms of montelukast sodium
08/18/2005WO2004026837A3 Histamine h3 receptor antagonists, preparaton and therapeutic uses
08/18/2005US20050182259 Subjecting a substituted quinoline-3-carboxamide compound to Hofmann degradation to obtain amine derivative, forming diazonium salt by reacting amine derivative with borontrifluoride-ethyl ether complex, heating to form 3-fluoroquinolines; intermediate for forming antibacterial compound
08/18/2005US20050182253 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182087 antidiabetic agents; type 2 diabetes; e.g. 1-Ethyl-6-(1-ethynylcyclohexylamino)-7-methyl-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylate
08/18/2005US20050182085 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005CA2554927A1 Stable amorphous forms of montelukast sodium
08/18/2005CA2554789A1 Montelukast sodium polymorphs
08/18/2005CA2554572A1 Montelukast free acid polymorphs
08/18/2005CA2551566A1 Diurea derivatives
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1563852A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils
08/17/2005EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1499594B1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1099694B1 Process for the preparation of quinoline derivative and intermediate therefor
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/16/2005US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide
08/16/2005US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005US6929870 Hydrocarbon compounds, materials for organic electroluminescent elements and organic electroluminescent elements
08/11/2005WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005WO2005073229A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073194A2 Solid forms of montelukast acid
08/11/2005WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
08/11/2005WO2005058835A3 Methods of preparing aripiprazole crystalline forms
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005023188A3 Compounds and methods
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004110983A8 New benzamides as pparϒ modulators